Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

Clinical trial NCT04865887 · RECRUITING

Trial details

NCT number: NCT04865887
Sponsor: Georgetown University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer Metastatic Cervical Cancer

Start date: 2022-10-07
Primary completion: 2026-07-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.